Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin enacarbil in post-herpetic neuralgia
NCT00619476Phase 2Completed
- Sponsor
- XenoPort, Inc.
- Start
- Feb 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of gabapentin enacarbil in postherpetic neuralgia (PHN), sponsored by XenoPort, Inc.. Started Feb 2008; status: completed.
02
Drugs
gabapentin enacarbil
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00619476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00619476.